CRISPR never generates a uniform genotype which complicates analyzing the targeted gene’s role without establishing clonal lines. Here we give examples of how the generated genetic heterogeneity can be leveraged for discovery –> RCC!
Very interesting study from Xiang X et al. about gRNA efficiency prediction, including a web based software CRISPRon for gRNA design (https://rth.dk/resources/crispr/crispron/).
2024 / Interview in The Scientist about a CRISPR screen study, link:
2021 / Interview for CMM news (text by Magdalena Lindén) :
2021 / Interview for Nordic Life Science about the Nobel Prize in Chemistry for CRISPR (p. 38-43 here in English):
2020 / Interview for KI about the Nobel Prize in Chemistry for CRISPR (here in Swedish):
2020 / Interview for Reumatikervärlden, the membership magazine of the Swedish Rheumatism Association (in Swedish). Rumatikervärlden number 2 2020 page 36-37 (interview by Annika Sjöberg):
2018 / Text (Swedish) for the membership magazine Legatus Mensae (“A strong Immune System”):
2005 / Text for the student magazine “Bukpressen”:
Great work by Sanjay Boddul in the lab developing methods to study T cell receptors cloned from patients! The presented experimental pipeline enables rapid development of relevant humanized animal models for studying novel antigen-specific tolerance therapeutics.
Boddul SV, Sharma RK, Dubnovitsky A, Raposo B, Gerstner C, Shen Y, Iyer VS, Kasza Z, Kwok WW, Winkler AR, Klareskog L, Malmström V, Bettini M, Wermeling F.
In vitro and ex vivo functional characterization of human HLA-DRB1*04 restricted T cell receptors.